Vegzelma, Celltrion's Avastin biosimilar, approved for sale in Australia

Celltrion's biosimilar of the anti-cancer drug Avastin, marketed as Vegzelma, was approved for sale in Australia, the Incheon-based biopharmaceutical company said Wednesday.